Roger MD - Addex Therapeutics Chief Director

ADXN Stock  CHF 0.07  0  7.54%   

Insider

Roger MD is Chief Director of Addex Therapeutics
Age 66
Phone(41) 22 884 15 56
Webwww.addexpharma.com

Addex Therapeutics Management Efficiency

The company has return on total asset (ROA) of (0.8786) % which means that it has lost $0.8786 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (2.0267) %, meaning that it generated substantial loss on money invested by shareholders. Addex Therapeutics' management efficiency ratios could be used to measure how well Addex Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 194.32 K in total debt. Addex Therapeutics has a current ratio of 17.7, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Addex Therapeutics until it has trouble settling it off, either with new capital or with free cash flow. So, Addex Therapeutics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Addex Therapeutics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Addex to invest in growth at high rates of return. When we think about Addex Therapeutics' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Fabienne GschwindEvolva Holding SA
50
Luigi LongoCOSMO Pharmaceuticals SA
44
Roberto GalliNewron Pharmaceuticals SpA
N/A
Dario EklundSanthera Pharmaceuticals Holdin
55
Astrid SchaferEvolva Holding SA
50
Christian WichertEvolva Holding SA
N/A
Stefan WeberNewron Pharmaceuticals SpA
58
Mauro AjaniCOSMO Pharmaceuticals SA
68
Biagio ViganoCOSMO Pharmaceuticals SA
49
Oliver MBAEvolva Holding SA
54
Peer SchroderBasilea Pharmaceutica AG
N/A
David VeitchBasilea Pharmaceutica AG
58
Shabir MDSanthera Pharmaceuticals Holdin
N/A
Lutz WevelsiepBasilea Pharmaceutica AG
N/A
Adesh KaulBasilea Pharmaceutica AG
49
Sarah HolmesKlotzSanthera Pharmaceuticals Holdin
N/A
Carsten DaweritzEvolva Holding SA
50
Eva KaliasSanthera Pharmaceuticals Holdin
N/A
Gnther MetzSanthera Pharmaceuticals Holdin
65
Thomas CFAEvolva Holding SA
N/A
Marc MDBasilea Pharmaceutica AG
59
Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system disorders in Switzerland. Addex Therapeutics Ltd was founded in 2002 and is headquartered in Plan-les-Ouates, Switzerland. ADDEX N operates under Biotechnology classification in Switzerland and is traded on Switzerland Exchange. It employs 17 people. Addex Therapeutics (ADXN) is traded on SIX Swiss Exchange in Switzerland and employs 26 people.

Management Performance

Addex Therapeutics Leadership Team

Elected by the shareholders, the Addex Therapeutics' board of directors comprises two types of representatives: Addex Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Addex. The board's role is to monitor Addex Therapeutics' management team and ensure that shareholders' interests are well served. Addex Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Addex Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
Timothy Dyer, CEO CoFounder
Werner Henrichi, Consultant
Mikhail Kalinichev, Head Science
JeanPhilippe Rocher, Head Chemistry
Roger MD, Chief Director
Lnaic Teyssdou, Head Fin
Robert Lutjens, Head Biology

Addex Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Addex Therapeutics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Addex Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Addex Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Addex Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving against Addex Stock

  0.76LISP Chocoladefabriken LindtPairCorr
  0.74LISN Chocoladefabriken LindtPairCorr
  0.42METN Metall Zug AGPairCorr
The ability to find closely correlated positions to Addex Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Addex Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Addex Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Addex Therapeutics to buy it.
The correlation of Addex Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Addex Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Addex Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Addex Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Addex Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Addex Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Addex Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Addex Therapeutics Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Addex Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Addex Stock please use our How to Invest in Addex Therapeutics guide.
You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Complementary Tools for Addex Stock analysis

When running Addex Therapeutics' price analysis, check to measure Addex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Addex Therapeutics is operating at the current time. Most of Addex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Addex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Addex Therapeutics' price. Additionally, you may evaluate how the addition of Addex Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Please note, there is a significant difference between Addex Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Addex Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Addex Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.